Health, Education & Government Healthcare Providers Value-Based Care & Population Health

Quality Measures

Clinical, operational, and financial complexity where patient outcomes, revenue, and compliance all intersect.

Cotiviti Inovalon Health Catalyst Truven Health (IBM)
Inside this journey
  1. Customer Discovery

    Surface reporting obligations, current abstraction workflows, EHR/data constraints, and success signals tied to reimbursement and public ratings.

    Discovery Questions

    Getting Oriented: What's Top of Mind for Your Team?

    • In one sentence, what is the single highest-priority quality reporting outcome your team must deliver this year?
    • Which reporting programs are highest priority for you right now? Options: CMS (e.g., Hospital QRP, HAC, HEDIS/MIPS), State/regulatory reporting, Commercial payer contracts, Accreditation reporting (e.g., The Joint Commission), All of the above, Other
    • Who on your team feels the most pressure when reporting season approaches—and why?
    • How do you currently measure whether your reporting activities are on track (targets, cadence, owners)? Options: Weekly dashboard, Monthly review, Ad hoc checks, Only at submission time, Other
    • When reporting goes well, what specific downstream impact do you see (e.g., avoided penalties, improved star ratings, stronger payer contracts)?

    Are You Quietly Losing Revenue — Or Is It Just Stress?

    • How confident are you that current quality measure results accurately protect your expected reimbursement? Options: Very confident, Somewhat confident, Unsure, Not confident
    • Tell us about the last time a quality score affected revenue or contract performance—what happened and who felt the impact?
    • Which of the following financial risks have you experienced or are you most worried about? Options: Direct payment penalties, Lost shared savings, Negative contract renegotiation, Reduced incentive payments, Public-rating-driven patient loss, None yet, Other
    • How closely do your finance and quality teams coordinate on reporting outcomes and forecasts? Options: Tightly integrated, Occasional alignment, Separate with limited communication, No routine coordination
    • If a 1–3% reimbursement swing was on the table, what would change about how you prioritize measurement and validation?

    Where Does Your Data Hide Its Secrets?

    • How often do you discover that the EHR or data extracts don't contain the elements you need to calculate a measure? Options: Almost always, Often, Sometimes, Rarely, Never
    • Which EHR(s) and ancillary systems host the records you must use for quality reporting? Options: Epic, Cerner/Oracle, MEDITECH, Allscripts, Athenahealth, Hybrid/multiple vendors, Other
    • Where do you see the most consistent data gaps or ambiguities (structured fields, free-text notes, scanned documents, external PDFs, interfaces)? Options: Structured fields, Free-text / notes, Scans / PDFs, External systems / HIE, Interfaces / integrations, Other
    • How accessible is sample clinical data for analysis (e.g., deidentified extracts, test FHIR feeds, CCDs)? Options: Full access to extracts/feeds, Limited test data only, Only production views with restrictions, No easy access yet, Other
    • Give an example of a measure field that regularly causes mapping disagreements—what are the specific definitions and where do they diverge?

    How Much of Abstraction Is a Bottleneck (And Where)?

    • If your abstraction process could talk back, what would it say is the single biggest pain point it faces daily?
    • Describe your current abstraction team: headcount, full-time vs. part-time, turnover cadence, and geographic distribution.
    • Which of these best describes your abstraction workflow today? Options: 100% manual chart review, Manual review with basic digital tools, Hybrid: automated pre-fill + manual confirmation, Primarily automated with human exceptions, Other
    • How long does it typically take from case identification to closed abstraction for a single chart? Options: <24 hours, 1–3 days, 4–10 days, 2–4 weeks, >1 month
    • What error, discrepancy, or rework rates do you track for abstractions, and how do those typically trend during peak reporting?

    When Will You Know the Numbers Are Right?

    • What tolerance for variance against a manual benchmark would you accept before you’d consider an automated calculation 'validated'? Options: Exact match required, Within 1–2% variance, Within 3–5% variance, Within 6–10% variance, Depends on the measure
    • How do you currently validate measures before submission (parallel runs, random audit, full reconciliation, external audit)? Options: Parallel automated vs manual, Sample-based audit, 100% manual reconciliation, Post-submission corrections only, Other
    • Who signs off on acceptance criteria for measure outputs—what stakeholders or committees must be convinced? Options: Quality Director/COO, Clinical leads / CMOs, Compliance/Risk, Finance, IT/Analytics, All of the above, Other
    • Describe a prior validation failure or near-miss: what root cause was identified, and what changes were put in place?
    • How much time and resource do you budget to reconcile discrepancies and prepare submission-ready files? Options: Minimal (<5% of team time), Moderate (5–15%), Significant (15–30%), Major (>30%)

    Who Needs to Own This Change (And Who Will Block It)?

    • If I told you implementing an automated abstraction solution will require a week of cross-department work, who would push back first—and why?
    • Which stakeholders must be involved for data access, clinical mapping, and validation (pick all that apply)? Options: Quality/Compliance, IT/Integration, Clinical leadership, Abstractors/ops, Finance, Legal/Privacy, Executive sponsor, Other
    • What approvals or governance checkpoints will any vendor-driven change require (e.g., security review, contracting, CIO sign-off)? Options: Security review, Business associate agreement (BAA), Contract/rates approval, Clinical steering committee, No formal checkpoints, Other
    • Who will be the day-to-day owner from your side for configurations, sample data access, and acceptance tests?
    • How do change initiatives typically falter here—capacity, competing priorities, unclear ownership, or technical blockers? Options: Capacity, Competing initiatives, Unclear ownership, Technical/EHR limitations, Budget constraints, Other

    If This Worked, What Would Next Year Feel Like?

    • Imagine next year's reporting closes and you exceeded your targets—what concrete differences would you notice (staff workload, time to submission, score improvements)?
    • Which measurable outcomes would make you say the project was a success (pick up to three)? Options: Reduced abstraction hours, Improved measure accuracy, Faster submission timelines, Higher public ratings, Reduced penalties, Lower validation rework, Other
    • How would improved measurement free up capacity or create new opportunities for your team or clinicians?
    • What would losing that improvement look like—what risks or negative consequences are you trying to avoid?
    • If we delivered a pilot that showed <3% variance from manual benchmarks and cut abstraction time by half, how would you want to scale it? Options: Roll across measures, Pilot more sites first, Negotiate commercial terms, Delay until next year, Other

    Practical Next Steps: Are We Ready to Move Toward a Pilot?

    • Which of these readiness items do you already have in place for a pilot? Options: Deidentified sample data, EHR test environment or FHIR access, Executive sponsor, Abstractor participation, Clear acceptance criteria, None of the above
    • How quickly could you provide a representative sample of charts and measure specs for initial mapping and validation? Options: Within 1 week, 1–2 weeks, 2–4 weeks, Longer than 1 month, Unsure
    • What concerns would you want addressed before authorizing a pilot (data security, scope, cost, resource time)? Options: Data security/compliance, Scope clarity, Commercial terms, Staff time commitments, Technical feasibility, Other
    • Who should we bring into an initial kickoff meeting from your side (names/roles), and who needs to be in the final sign-off conversation?
    • What would be a reasonable decision timeline after we present a pilot plan and initial findings? Options: Immediately / same week, Within 2 weeks, 1 month, 2–3 months, Longer / unsure
  2. Solution Experience

    Validate how the platform will map their EHR, automate abstraction, and improve measure accuracy using the customer’s actual measures and sample charts.

    Experience Meetings

    • Current State & Success Criteria Alignment
    • EHR Data Mapping Workshop (Field-by-Field)
    • Automated Abstraction Simulation (Run on Customer Charts)
    • Accuracy Validation & Discrepancy Resolution
    • Decision Review & Next Steps to Scope
    • Host: Produce a detailed validation report with metrics, discrepancy log, and remediation proposals for each measure.
    • Host: Propose rule/NLP tweaks or additional mapping to reduce high-frequency exceptions identified in the run.
    • Customer: Confirm whether the observed automated coverage meets their operational expectations or needs further tuning.
    • Present Validation Metrics (per-measure)
    • Provide a validated accuracy report that quantifies gaps versus manual abstraction.
    • Classify each discrepancy with an owner and remediation action to improve automated accuracy.
    • Mutually agree on per-measure acceptance thresholds and a deadline for remediation.
    • Confirm need and scope for any additional training or specification clarifications.
    • Introductions & Meeting Objectives
    • Customer: Review and adjudicate remaining disputed cases and confirm final ground-truth outcomes.
    • Host & Customer: Create a prioritized remediation backlog with owners, changes, and target completion dates.
    • Customer: Confirm acceptance thresholds and sign-off criteria to enable transition to Solution Scope.
    • Executive Summary of Findings
    • Decision to proceed to Solution Scope or a documented list of gating items if not ready.
    • Agree on initial deployment scope, validation targets, and timeline aligned to reporting cycles.
    • Assign owners for scope deliverables and sign-off on acceptance criteria required for deployment.
    • Document risks and mitigation actions that must be addressed in the Solution Scope phase.
    • Customer: Provide formal approval to proceed or a written list of gating items that require resolution.
    • Host: Draft a Solution Scope summary (measures, interfaces, validation plan, timeline, SOW skeleton) for customer review.
    • Host: Update the remediation backlog with committed deadlines and owners based on validation outcomes.
    • Customer & Host: Schedule handoff workshops for Deployment group once scope is approved.
    • Produce one-sentence current state statement signed off by customer stakeholders.
    • Agree and document quantified consequences tied to KPIs that make the problem urgent.
    • Define one-sentence future state and 2–3 measurable success signals to prove during the experience.
    • Confirm available sample charts, measures, and data extracts required for subsequent sessions.
    • Customer: Provide a signed one-sentence current state and 3 consequence metrics (e.g., FTE hours, missed revenue).
    • Customer: Deliver a defined set of sample charts (suggest 25–50 records covering edge cases) and manual abstraction benchmark data.
    • Host: Prepare a mapping template and success-signal tracker to use across the experience meetings.
    • Host: Confirm technical contacts and required access method (FHIR/API/SFTP) and schedule the EHR mapping workshop.
    • Review Extract Sample & Field Inventory
    • Complete field-level mapping for prioritized measures with mapped/unmapped status documented.
    • Agree on mitigation strategy for each unmapped element (NLP, manual abstraction, proxy), with owner assigned.
    • Confirm extraction method, cadence, and test payload to be provided by customer.
    • Establish clear validation checks that gate the next automation simulation.
    • Customer: Provide a secured test extract or sandbox access containing agreed sample records and field-level documentation.
    • Host: Populate the shared mapping workbook with field mappings and mitigation notes and return for customer review.
    • Customer & Host: Agree and document validation checks and success thresholds that the extract must satisfy.
    • Customer: Identify an SME (clinical abstractor or informaticist) to join the next simulation session for adjudication.
    • Pre-test Checklist & Baseline Reminder
    • Demonstrate the platform producing extraction and automated abstraction outputs on customer's real charts.
    • Identify and categorize exceptions and edge cases requiring human review or rule refinement.
    • Obtain SME confirmation (or corrective feedback) on automated decisions for sampled cases.
    • Document expected reduction in manual steps and any remaining manual touchpoints.
    • Host: Deliver the raw extracted dataset, automated abstraction outputs, and exception logs from the simulation.
    • Customer: Provide adjudications for discrepancies in the sampled cases and annotate rationale where manual judgment applied.
    • Measure-by-Measure Mapping (interactive)
    • Customer Current State (one sentence)
    • Case-by-Case Discrepancy Review
    • Review of Agreed Acceptance Criteria & Validation Results
    • Live Run: Automated Extraction & Abstraction
    • Scope for Next Phase (measure set, interfaces, abstraction coverage)
    • Unstructured Data & Workarounds
    • Root Cause Classification & Remediation Plan
    • Consequence Quantification
    • Review of Exceptions & Edge Cases
    • Future State Definition (one sentence) + Success Signals
    • Timeline Alignment to Reporting Cycles & Commitments
    • Extraction Method & Frequency
    • Tying Outputs to Measure Rules
    • Agree on Validation Targets & Acceptance Criteria
  3. Solution Scope

    Define measure sets, EHR interfaces, abstraction coverage, validation targets, training, and delivery milestones.

    Scope Configuration

    • Configure EHR Interface for eCQM Extraction
    • Map Measure Specifications to EHR Data Elements
    • Deploy Automated Chart Abstraction Engine
    • Implement Abstraction Exception Handling and Routing
    • Identify Care Gaps and Generate Provider Alerts
    • Calculate Measure Scores and Compliance Rates
    • Generate Submission-Ready Reports and Files
    • Submit Measures to CMS, Payers, and Registries
    • Integrate HEDIS, MIPS, Hospital, and ACO Libraries
    • Launch Measure Trend Analysis Dashboards
    • Train Abstraction Team on Platform Workflows
    • Configure Audit Trail and Change Tracking

    Scope Questions

    Configure EHR Interface for eCQM Extraction

    • Which EHR vendor(s) and version(s) are in scope for extraction?
    • Which data access methods are available or preferred for integration? Options: FHIR (R4/R3), Direct API / Proprietary API, HL7 v2 feeds, C-CDA/CCD, Database query / ETL, SFTP / flat file export
    • Do you have existing eCQM endpoints or export mappings configured in the EHR? Options: Yes - eCQM endpoints available, Partially - some endpoints available, No - need to configure
    • Is there an internal IT/HIT resource assigned to support connectivity (name/role and weekly hours available)?
    • Are sandbox/test instances and synthetic/sample data accessible for initial integration? Options: Yes - full sandbox available, Limited test data available, No sandbox/test environment
    • Do you require VPN, IP allow-listing, or special security/compliance controls for the interface? Options: Yes - VPN/IP restrictions, Yes - specific org security controls, No special controls
    • What is the expected monthly chart / encounter volume to be extracted? Options: < 1,000, 1,000–10,000, 10,000–50,000, > 50,000

    Map Measure Specifications to EHR Data Elements

    • Which measure libraries and specific measures should be mapped initially?
    • Are there local/custom measures or payer-specific definitions that differ from standard specs? Options: Yes - multiple local/custom measures, Yes - a few variations, No - standard specs only
    • Who will own final mapping decisions when EHR element ambiguity exists (customer SME, vendor, joint review)? Options: Customer SME, Customer SME with vendor validation, Vendor-led (with customer approval)
    • Do clinical concepts live in structured fields, free-text notes, scanned documents, or external systems? Options: Structured fields, Free-text clinical notes, Scanned/PDF documents, External registries / systems
    • Are value sets/code systems (e.g., LOINC, SNOMED, ICD) standardized across sites, or are local codes used? Options: Standardized (LOINC/SNOMED/ICD), Mixed standard and local codes, Primarily local/custom codes
    • What acceptance criteria do you require for mapped elements (e.g., coverage %, manual override allowance)? Options: Coverage target (e.g., 90%+), Allow manual overrides with audit, Strict automated-only mapping, Other

    Deploy Automated Chart Abstraction Engine

    • What percent of charts do you expect to be auto-abstracted vs. manually abstracted initially? Options: <25%, 25-50%, 50-75%, >75%
    • Which care settings are in scope for automated abstraction (e.g., inpatient, outpatient, ED, post‑acute)? Options: Inpatient, Outpatient/ambulatory, Emergency Department, Post-acute / SNF, All of the above
    • Are scanned documents / PDFs and image-based records required for abstraction? Options: Yes - a lot, Some, No
    • What throughput and SLA do you require for automated abstraction processing? Options: Near real-time, Daily batch, Weekly, Custom schedule
    • Will the abstraction engine need to integrate with existing human abstraction queues/workflows? Options: Yes - tight integration, Partial integration, No - separate workflows
    • What accuracy/validation target should the engine meet before we reduce manual review (e.g., F1 score, percent agreement)?

    Implement Abstraction Exception Handling and Routing

    • What exception types should trigger human review (e.g., low-confidence extractions, missing data, conflicting data) ? Options: Low-confidence extraction, Missing critical fields, Conflicting data points, Business-rule violations, Other
    • How should exceptions be routed by priority or type (e.g., to specific abstractors, clinical leads, or specialty teams)? Options: Role-based routing, Team-based queues, Escalate to clinical lead, Round-robin assignment
    • What SLA times do you require for exception resolution (e.g., 24/48/72 hours)? Options: Same day, 24 hours, 48 hours, 72 hours, Custom
    • Which notification channels should be used for exceptions (EHR inbox, email, platform task, pager)? Options: EHR inbox, Email, Platform task/notifications, Slack/MS Teams, Other
    • Do you require audit logging and reason capture for each exception and resolution? Options: Yes - full audit required, Partial audit (critical fields only), No
    • Should certain exceptions be auto-escalated to leadership or compliance teams for review? Options: Yes - auto-escalate, No - manual escalation only, Conditional

    Identify Care Gaps and Generate Provider Alerts

    • Which care gap types should be detected and surfaced (e.g., missing immunizations, overdue screenings, medication reconciliation)?
    • Do you prefer real-time alerts at encounter time or periodic batch alerts to providers/care teams? Options: Real-time (encounter), Daily batch, Weekly summary, Both real-time and batch
    • Which alert channels are acceptable for provider notifications (EHR inbox, in-workflow CDS, email, secure messaging)? Options: EHR inbox/CPOE, In-workflow CDS, Email, Secure messaging, Mobile push
    • Should alerts include suggested actions and documentation templates or only flags? Options: Include suggested actions and templates, Flags only, Configurable per measure
    • Who will own closing gaps: primary care, specialists, care coordinators, or centralized quality team? Options: Primary care, Specialists, Care coordinators, Centralized quality team, Mixed model
    • How should false-positive alerts be reported and used to refine detection logic? Options: Report via feedback UI, Periodic review meetings, Automated learning from feedback, Other

    Calculate Measure Scores and Compliance Rates

    • Which reporting periods and cadences must the calculation engine support (e.g., calendar year, rolling 12 months, quarterly)? Options: Calendar year, Rolling 12 months, Quarterly, Custom reporting periods
    • What tolerance or acceptance thresholds do you require before considering scores production-ready (e.g., +/- X% vs manual benchmark)?
    • Do you require denominator/exclusion adjudication rules to be customized for payer programs? Options: Yes - payer-specific customization, No - standard rules only, Some payers require tweaks
    • Should the system support stratified reporting (by site, provider, patient cohort) and risk adjustment? Options: Site-level, Provider-level, Patient cohort, Risk adjustment required, All of the above
    • How frequently should reconciliations and re-calculations run after data fixes (immediate, nightly, monthly)? Options: Immediate/near real-time, Nightly, Weekly, Monthly
    • Are there specific rounding, suppression, or minimum-n size rules we must apply for public reporting? Options: Yes - provide spec, No special rules, Use standard CMS suppression rules

    Generate Submission-Ready Reports and Files

    • Which file formats and standards are required for submissions (e.g., QRDA I/III, CSV, XML, HL7)? Options: QRDA I, QRDA III, CSV/Flat file, XML, Other
    • Do you require pre-submission validations and schema checks in-platform before export? Options: Yes - mandatory pre-checks, Optional checks, No pre-checks required
    • Who will approve final submission-ready files (role/title) and how should approvals be captured?
    • What delivery method is preferred for finalized files (secure SFTP, direct portal upload, vendor submission)? Options: Secure SFTP, Portal upload, Vendor submits on behalf, Email (not recommended)
    • How many report templates and recipient lists need to be configured (e.g., internal leaders, payers, registries)?
    • Do you need scheduled automated exports and distribution (daily/weekly/monthly)? Options: Yes - scheduled exports, No - manual only, Mixed

    Submit Measures to CMS, Payers, and Registries

    • Will your organization submit directly to CMS/payers/registries or require vendor-assisted submission? Options: Customer submits directly, Vendor submits on behalf, Hybrid (vendor prepares, customer submits)
    • Do you have existing submitter credentials and access to each destination (CMS ID, payer portals)? Options: Yes - all credentials ready, Partial - some portals, No - credentials need provisioning
    • Do you require dry-run test submissions and reconciliation reports prior to official submission windows? Options: Yes - required, Optional, No
    • Who is responsible for attestations, sign-offs, and legal declarations for final submissions?
    • Should submission processes include automated confirmation and error-handling workflows (retries, error alerts)? Options: Yes - automated retries/alerts, Basic notifications only, No automation required
    • Are there payer- or registry-specific business rules or file transforms required post-export? Options: Yes - multiple transforms required, Some payers require transforms, No special transforms

    Integrate HEDIS, MIPS, Hospital, and ACO Libraries

    • Which libraries do you require in scope at launch (select all that apply)? Options: HEDIS, MIPS, Hospital inpatient measures, ACO measures, State-specific libraries
    • Do you need historical measure versions supported for look-back or reconciliation? Options: Yes - historical versions required, No - current year only, Some historical support needed
    • How often do you expect measure library updates to be applied (annual, quarterly, as-released)? Options: Annually, Quarterly, As-released, Custom cadence
    • Are there local payer/program variations to standard library definitions that must be modeled? Options: Yes - many variations, A few variations, No
    • Who should own change control and version approval for library updates (customer, vendor, joint governance)? Options: Customer-owned, Vendor-managed with notification, Joint governance
    • Do you require mapping reports that show EHR element -> value set -> measure mapping for audit/regulatory review? Options: Yes - detailed mapping reports, Summary mapping only, No mapping reports required

    Launch Measure Trend Analysis Dashboards

    • Which KPIs and views are highest priority for dashboards (e.g., measure-level trend, provider performance, gap closure rate)?
    • What time granularity is required (daily, weekly, monthly, rolling 12-month)? Options: Daily, Weekly, Monthly, Rolling 12-month, Custom
    • Which user roles need access and what level of drill-down should each role have? Options: Executive (high-level), Quality lead (site-level), Abstractors (case-level), Clinicians (provider-level)
    • Do you require embedded explanations of measure calculation logic and data lineage within dashboards? Options: Yes - show data lineage, Basic calculation notes, No
    • Should dashboards support scheduled distribution and export formats (PDF, CSV)? Options: PDF, CSV/Excel, API export, All of the above
  4. Mutual Commit

    Agree commercial terms, acceptance criteria, data access responsibilities, and timeline aligned to reporting cycles.

    Agreement Modules

    • Statement of Work (SOW)
    • Master Services Agreement (MSA)
    • Business Associate Agreement (BAA)
    • Data Processing Agreement (DPA)
    • Pricing & Payment Schedule
    • Acceptance Criteria & Validation Plan
    • EHR Interface & Data Access Matrix
    • Timeline & Reporting Cycle Alignment
    • Implementation Roles, RACI & Escalation
    • Training & Knowledge Transfer Plan
    • Change Order & Scope Management
    • Compliance, Audit Rights & Security Controls
    • Termination, Data Return & Offboarding Plan
    • Final Sign-off & Go‑Live Authorization
  5. Deployment

    Operationalize rollout with readiness checks, enablement, and outcome validation.

    1. Pre-Deployment Readiness

      Confirm EHR connectivity, sample data availability, abstraction team roles, and risk controls before configuration begins.

      Readiness Questions

      Start Here: Tell Us About Your Reporting Reality

      • Which reporting programs does your organization currently submit to (select all that apply)? Options: CMS Hospital Quality (e.g., HAC, PSI), MIPS/Promoting Interoperability, HEDIS, ACO / MSSP, State quality programs, Commercial payers (contractual measures), Other
      • How frequently do you run measure reporting cycles internally (select best fit)? Options: Continuous/real-time, Monthly, Quarterly, Annually or as-needed, Ad-hoc prior to submission
      • Who is the primary owner of measure submission and sign‑off in your organization? Options: Chief Quality Officer, Director of Quality/Population Health, Compliance Officer, Clinical Informatics/CMIO, Revenue Cycle/Finance, Shared responsibility, Other
      • Which 3 measures or measure families cause you the most operational effort or anxiety? Please name them and why.
      • Roughly what percent of your final reported measures are validated against manual abstraction each cycle? Options: >75%, 50–75%, 25–50%, <25%, None

      Why Your Published Score May Be Hiding a Problem

      • What if your published quality score is masking recurring data gaps that cost you revenue and reputation—where would you start looking?
      • Can you share a recent example where a reported metric surprised leadership after submission? What changed between your internal view and the published result?
      • How confident are you today that your calculated rates match manual chart review across high‑impact measures? Options: Very confident (≤1% discrepancy), Moderately confident (1–5% discrepancy), Somewhat unsure (5–10%), Not confident (>10%), I don't know
      • When discrepancies are found, who typically investigates and how long does resolution take? Options: Quality team, Clinical informatics, IT/EHR vendor, Third‑party auditor, Combination, Other
      • How do these gaps feel internally—annoying operational work, a compliance risk, a financial threat, or something else? Options: Operational annoyance, Compliance risk, Financial threat, Executive visibility problem, Erodes staff morale, Other

      Where the Data Gets Lost — EHR, Interfaces, and Reality

      • Which parts of your EHR routinely fail to map cleanly to measure specifications (think fields, flowsheets, scanned content)? Options: Structured clinical fields, Flowsheets/obs data, Progress notes/free text, Scanned documents/images, Orders/med lists, External HIE/claims
      • Which EHR(s) and versions are in scope for your reporting population?
      • Do you currently expose any of the following interfaces for extract: FHIR API, C-CDA, SQL extracts, flat files, or vendor-specific feeds? Options: FHIR APIs, C‑CDA bundles, Direct SQL extracts, SFTP flat files/CSV, Vendor proprietary feed, None / planned
      • How accessible are sample charts and raw extracts for our engineers and validators to review (pick best answer)? Options: Available now with PHI-safe process, Available after DTA/BAA, Limited samples only, Not available / requires heavy coordination
      • Tell us about any major customizations or home‑grown modules clinicians depend on that we should know about.
      • Which data quality issues do you see most often (select all that apply)? Options: Missing timestamps, Duplicated encounters, Inconsistent code usage (ICD/CPT/LOINC), Free‑text only clinical evidence, Delayed documentation, Other

      The Human Cost: Your Abstraction Team and Their Bottlenecks

      • How much institutional knowledge is trapped in individual abstractors’ heads versus documented in processes? Options: Mostly tribal (individuals), Partially documented, Well-documented and standardized, I don't know
      • How large is your abstraction team and how is work currently allocated (roles and FTEs)?
      • On average, how long does a single manual abstraction take for a typical measure chart? Options: <15 minutes, 15–30 minutes, 30–60 minutes, >60 minutes, Varies widely by measure
      • What training and competency processes exist for new abstractors, and how often are they refreshed? Options: Formal onboarding + periodic refresh, Onboarding only, Ad hoc mentoring, No formal process
      • Where do abstractors spend the most time—finding documentation, interpreting clinician notes, reconciling conflicting records, or something else? Options: Searching for documents, Interpreting free text, Reconciling conflicting sources, Data entry/QA, Waiting for access
      • How does turnover or seasonal staffing affect your ability to meet reporting deadlines?

      Contracts, Incentives, and What Keeps Executives Awake

      • If your next reimbursement adjustment hinged on a single measure, which one would you be most worried about and why?
      • Which of the following drive the highest financial or reputational risk for you? Options: CMS payment adjustments, State compliance penalties, Commercial contract penalties, Public rating/consumer-facing scores, Shared savings programs
      • How often do measurement specifications differ across your payers or programs in ways that force manual reconciliation? Options: Always, Often, Sometimes, Rarely, Never
      • Who in leadership needs to be convinced that automation is worth the investment (roles)? Options: CNO, CFO, CMO/CMIO, Chief Quality Officer, VP Population Health, Other
      • When contracts require attested data, what internal acceptance criteria do you apply before sign‑off?

      What Would Real Confidence Look Like for Your Team?

      • Imagine never having to defend a submission—what would have changed in your processes, systems, and people?
      • What accuracy threshold (discrepancy between automated and manual) would make you comfortable moving to automated submissions? Options: ≤1% discrepancy, 1–3%, 3–5%, >5%, Not sure
      • Which validation outputs would you want visible on a dashboard to feel confident (select all that apply)? Options: Measure-level pass rates vs manual, Source-level reconciliation logs, List of cases requiring manual review, Trend of data completeness, Audit trail of changes
      • What timeline and milestones feel realistic for you from initial config to submission‑ready for a single measure set? Options: <4 weeks, 4–8 weeks, 2–3 months, 3–6 months, Depends on EHR integration
      • What would be the single best signal that automation is 'working' for your organization? Options: Reduced manual FTE hours, Improved reported score, Fewer post‑submission corrections, Faster time to submission, Executive satisfaction

      How Ready Are You to Move—Barriers, Resources, and Next Steps

      • What is the single biggest obstacle that would prevent you from starting an automation pilot within the next quarter? Options: IT bandwidth, Data access/privacy approvals, Budget, Leadership buy‑in, Staff resistance, Other
      • Who needs to sign off on data access and what approvals (BAA, IRB, security review) are required?
      • Would you be able to provide de‑identified or limited PHI sample datasets for engineering and validation work? If so, how many sample charts could you provide initially? Options: Yes — 50+ charts, Yes — 10–50 charts, Limited samples (≤10), No, not without approvals
      • How would you like us to demonstrate impact first—single high‑risk measure pilot, a handful of measures across modalities, or end‑to‑end submission simulation? Options: Single high‑risk measure pilot, Multi‑measure pilot (sample set), End‑to‑end submission simulation, Unsure — need recommendation
      • Who should be on a proposed steering committee for a pilot (names/roles) and how often can they meet?
      • Finally, what would make you feel comfortable committing to a next step with us (proof points, references, pilot pricing, security assurances)? Options: References from peers, Detailed pilot scope & ROI, Security & compliance docs, Flexible pilot pricing, Clear acceptance criteria
    2. Deployment Enablement

      Coordinate configuration, phased data ingest, abstraction workflows, and training with clear owners and timelines.

    3. Validation Checklist

      Run parallel validation against manual benchmarks, resolve specification gaps, and confirm submission‑ready outputs and reconciliation processes.

      Validation Questions

      Before we dive in — your quick snapshot

      • Tell us the best short description of your organization and reporting scope (size, inpatient/outpatient mix, number of facilities)
      • Which reporting programs do you currently submit to (select all that apply)? Options: CMS (e.g., Hospital QRP, HAC, MIPS), State public reporting, Commercial payer contracts, ACO/Value-based programs, Accreditation bodies, Other
      • Approximately how many distinct quality measures do you actively track and report today? Options: < 10, 10–25, 26–50, 51–100, > 100, Unsure
      • Who will be our primary contact for this discovery and implementation conversation (title/role)?
      • How soon are you expecting to start working with a vendor to address measurement and abstraction needs? Options: Immediately (0–1 month), Soon (1–3 months), This quarter (3–6 months), Later (6–12 months), No set timeline

      Are you settling for 'good enough' on quality reporting?

      • What gives you the sneaking suspicion your current process is masking worse performance than reality?
      • How often do inconsistencies between abstractor determinations and final submissions show up during internal reviews? Options: Weekly, Monthly, Quarterly, Rarely, We don't review
      • When a chart review or submission error is discovered, how long does it typically take to identify the root cause and resolve it? Options: Days, Weeks, Months, We rarely resolve root cause
      • Describe a recent example where a measure surprise affected reimbursement, public reporting, or a payer conversation
      • Which emotions come up most when you think about this part of your job (select up to three)? Options: Frustration, Anxiety, Exhaustion, Urgency, Skepticism, Hopeful, Resigned

      Where the data is lying to you (and why that matters)

      • If your EHR could tell the full truth about every measure, what would be different in your reporting today?
      • Which EHR(s) and version(s) are in scope for the measures we’d work on? Options: Epic, Cerner/Oracle, Allscripts, MEDITECH, athenahealth, Other, Multiple vendors
      • How much of the data for your measure set is captured in structured fields versus free text or scanned documents? Options: Mostly structured (>75%), Mixed (50/50), Mostly unstructured (>75%), Unknown
      • Do you currently have any automated eCQM feeds or APIs configured for measure extraction? Options: Yes, multiple feeds, Yes, limited feeds, No, Not sure
      • Are there specific interfaces, data marts, or clinical source tables you know we must access (e.g., ADT, flowsheets, C-CDA, pathology reports)? Please list them.

      What’s getting in the way of accuracy and timeliness?

      • What hidden assumptions about your abstraction process do you suspect are untrue?
      • Which parts of abstraction create the most variation between reviewers (select all that apply)? Options: Initial chart selection, Inclusion/exclusion determination, Interpretation of notes, Data entry errors, Timing of lookback windows, Other
      • How many full-time equivalent abstractors do you employ, and how much overtime or temp support do you use during peak reporting? Options: < 2 FTE, 2–5 FTE, 6–10 FTE, 11–20 FTE, > 20 FTE, Unsure
      • Tell us about turnover, training gaps, or institutional knowledge losses that have impacted abstraction quality
      • When there's disagreement between abstractors, what process do you use to arbitrate and document the final decision? Options: Peer review with consensus, Medical director adjudication, Random audit with retraining, No consistent process, Other

      What’s really at risk if things don’t change?

      • If reporting errors persist for another year, what financial, contractual, or regulatory consequences are you most worried about?
      • Which of these outcomes would be most damaging to your organization (ranked importance via selection)? Options: Lost reimbursement, Negative public ratings, Contract terminations, Regulatory investigations, Internal credibility loss, Other
      • How do payers or partners validate your reported measures today, and how often have those validations created disputes? Options: Frequent disputes, Occasional disputes, Rare disputes, We don't get validated
      • Have you ever been subject to retrospective recoupment or denied payments tied to quality scores? If so, describe briefly.
      • On a scale of 1–10, how critical is improving measure accuracy this year for your executive leadership? Options: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10

      Who owns the problem — and who has to say yes?

      • If we ran this engagement, who would sign the final statement of work and who would own ongoing vendor governance?
      • Which internal teams need to be actively involved for EHR access, data validation, and go‑live (select all that apply)? Options: Clinical Quality/Compliance, Health IT/Integration, Data Analytics/BI, Medical Staff/Physician leadership, Revenue/Finance, Legal/Privacy, Other
      • Do you currently work with external vendors for abstraction, analytics, or submissions? If yes, who and what are the main gaps?
      • Who are the internal champions and who are the likely skeptics for automation in quality measurement?
      • What procurement or contracting timelines or processes should we anticipate that could affect implementation? Options: Standard P.O. process, Committee approvals required, Formal RFP in progress, Contracting delays likely, Unsure

      What would a 'done' year look and feel like?

      • If we achieved everything you hoped for in a single measurement year, what would you notice first?
      • What accuracy and concordance targets would satisfy your auditors for automated abstraction compared to manual benchmarks? Options: > 98% concordance, 95–98%, 90–95%, 85–90%, Unsure
      • Which outputs must be submission‑ready from day one (select all that apply)? Options: Measure calculations, Patient lists with care gaps, Audit logs/reconciliation reports, Submission files (eCQMs/QPR), Clinician-facing flags, Other
      • What turnaround time do you expect between flagged cases and clinician notification for closing care gaps? Options: Same day, 24–48 hours, Within a week, Longer than a week, Not applicable
      • How will you measure success internally—what KPIs or executive-level metrics matter most?

      How much change can you actually absorb without breaking the day-to-day

      • We often see great plans fail in deployment—what scares you most about implementing automation in your environment?
      • What internal training bandwidth exists to onboard abstractors and clinicians to a new workflow? Options: Dedicated training team, Limited training resources, Ad-hoc peer training, None currently
      • Would you prefer a big-bang rollout, phased pilot by service line, or hybrid approach for deployment? Options: Phased pilot, Big-bang, Hybrid phased then scale, Unsure
      • Have you run pilots of automation or analytics before? What worked and what unexpectedly didn't?
      • Which months or reporting cycles are absolute no-go windows for configuration and tuning (e.g., major submissions, seasonal peaks)?

      What would make you trust us enough to run a validation side-by-side?

      • What manual benchmark or audit approach would you require for parallel validation (sample size, review cadence, adjudication method)? Options: Small sample weekly, Larger monthly sample, Continuous sampling, Ad-hoc as needed, Unsure
      • What reconciliation and audit trail features are non-negotiable for your compliance team? Options: Detailed audit logs, Change history per data point, Reviewer adjudication records, Automated reconciliation reports, Role-based access controls, Other
      • What data access, security, and privacy controls must we meet before any sample data leaves your environment? Options: Business Associate Agreement (BAA), On-prem connector only, Limited scoped access, Encrypted transfers, SOC/HITRUST requirements, Other
      • Would you be open to a timeboxed pilot with defined acceptance criteria to build trust before enterprise rollout? Options: Yes, pilot now, Yes, but later, No, prefer enterprise scope, Unsure
      • What would be the single decisive deliverable or demonstration that would get leadership to sign off?
  6. Success

    Review outcomes versus success signals, document lessons learned, and maintain a shared log for issues and enhancements.

    Success Reviews

    • Success Outcomes Review
    • Validation & Reconciliation Workshop
    • Lessons Learned & Continuous Improvement
    • Enhancement Backlog Prioritization & Roadmap
    • Ongoing Governance, Monitoring & Escalation Cadence

    Issues & Enhancements

    • Assign product/engineering owners and confirm resource allocation for committed items.
    • Ensure learnings are entered into the shared log and made accessible for future engagements.
    • Publish a formal Lessons Learned document and link it to the shared issues/enhancements log.
    • Create SOP update tickets and assign owners for each process change.
    • Schedule targeted training sessions addressing identified gaps.
    • Capture metrics to monitor the effectiveness of implemented process changes.
    • Review Shared Issues & Enhancements Log
    • Produce a prioritized enhancement backlog with impact/effort scores.
    • Agree a near‑term roadmap with milestones tied to reporting cycles and resource owners.
    • Commit resources and define next checkpoints for roadmap progress review.
    • Create prioritized epics in the project tracker with acceptance criteria and target milestones.
    • One‑sentence Current State Recap
    • Publish the roadmap and circulate to executive sponsors and operational teams.
    • Schedule a quarterly roadmap review aligned to reporting cycles.
    • Define Governance Roles & RACI
    • Establish a clear governance model with owners, SLAs, and triage rules for the shared log.
    • Agree a repeatable KPI review cadence and dashboard to detect and prevent measure drift.
    • Set escalation thresholds and a contact path to resolve high‑impact issues rapidly.
    • Configure and share the KPI dashboard and train owners on its use.
    • Provision access to the shared issues/enhancements log and enforce triage SLAs.
    • Publish the governance RACI and 90‑day meeting schedule to stakeholders.
    • Define automated alerts for threshold breaches and assign on‑call contacts.
    • Confirm whether the delivered outcomes meet the agreed success signals for acceptance.
    • Quantify the business impact of any deviations and agree remediation or mitigation actions.
    • Assign owners, timelines, and revalidation criteria for all identified gaps.
    • Publish a consolidated outcomes vs success signals report and distribute to stakeholders.
    • Create remediation tickets with owners and deadlines for all high‑priority gaps.
    • Schedule follow-up validation meeting and define re‑run data windows.
    • Update the shared issues/enhancements log with accepted decisions and statuses.
    • Pre‑work & Data Availability Check
    • Reconcile and document root causes for measure discrepancies with traceable evidence.
    • Produce a prioritized list of fixes with test cases that, when implemented, will move measures to acceptance criteria.
    • Agree objective re‑run and sign‑off criteria for each corrected measure.
    • Record and log each discrepancy with source evidence (chart IDs, screenshots, logs).
    • Create implementation tickets for each agreed fix with linked test cases.
    • Schedule the re‑run window and validation sampling approach.
    • Update measure specification mapping documentation where interpretation fixes are needed.
    • Timeline & Milestone Review
    • Document a prioritized set of lessons learned with supporting evidence.
    • Define and assign process improvements, SOP updates, and training actions to owners with timelines.
    • Monthly KPI Review Format
    • Value & Impact Scoring
    • What Worked / What Didn’t (Structured Retrospective)
    • Walkthrough: Sample Measures & Charts
    • Recap of Agreed Success Signals & Acceptance Criteria
    • Process Mapping — Abstraction & Escalation
    • Outcome Data Presentation
    • Shared Log Access, Triage Rules & SLAs
    • Root Cause Mapping
    • Feasibility & Effort Assessment
    • Escalation Paths & Decision Thresholds
    • Training & Role Adjustments
    • Backlog Prioritization & Roadmap Draft
    • Define Fixes and Test Cases
    • Consequence Analysis
    • 90‑Day Monitoring Schedule
    • Reconciliation Sign‑off Criteria
    • Agree Actionable Process Changes
    • Gap Triage & Immediate Decisions
    • Decision & Resource Commitments
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.